A review on expression and regulatory mechanisms of miR-337-3p in cancer

References

• Anastasiadou, E., Jacob, L. S., & Slack, F. J. (2018). Non-coding RNA networks in cancer. Nature Reviews. Cancer, 18(1), 5–18. https://doi.org/10.1038/nrc.2017.99
   PubMed Web of Science ®Google Scholar
• Cao, X.-M. (2019). Role of miR-337-3p and its target Rap1A in modulating proliferation, invasion, migration and apoptosis of cervical cancer cells. Cancer Biomarkers: Section A of Disease Markers, 24(3), 257–267. https://doi.org/10.3233/CBM-181225
   PubMed Web of Science ®Google Scholar
• Cheng, C., Zhang, H., Dai, Z., & Zheng, J. (2021). Circular RNA circVRK1 suppresses the proliferation, migration and invasion of osteosarcoma cells by regulating zinc finger protein ZNF652 expression via microRNA miR-337-3p. Bioengineered, 12(1), 5411–5427. https://doi.org/10.1080/21655979.2021.1965695
   PubMed Web of Science ®Google Scholar
• Cortini, M., Avnet, S., & Baldini, N. (2017). Mesenchymal stroma: Role in osteosarcoma progression. Cancer Letters, 405, 90–99. https://doi.org/10.1016/j.canlet.2017.07.024
   PubMed Web of Science ®Google Scholar
• Costa, F. F. (2010). Non‐coding RNAs: Meet thy masters. BioEssays, 32(7), 599–608. https://doi.org/10.1002/bies.200900112
   PubMed Web of Science ®Google Scholar
• Cui, H., Song, R., Wu, J., Wang, W., Chen, X., & Yin, J. (2018). MicroRNA-337 regulates the PI3K/AKT and Wnt/β-catenin signaling pathways to inhibit hepatocellular carcinoma progression by targeting high-mobility group AT-hook 2. American Journal of Cancer Research, 8(3), 405–421.
   PubMed Web of Science ®Google Scholar
• Dehghanian, M., Yarahmadi, G., Fazeli, J., Vahidi Mehrjardi, M. Y., Javaheri, A., Kalantar, S. M., & Dehghani, M. (2022). Evaluation of the relationship between miR-337-3p and RAP1A gene in endometriosis. Journal of Endometriosis and Pelvic Pain Disorders, 14(4), 178–182. https://doi.org/10.1177/22840265221099622
   Web of Science ®Google Scholar
• Dong, W., Li, B., Wang, J., Song, Y., Zhang, Z., & Fu, C. (2017). MicroRNA-337 inhibits cell proliferation and invasion of cervical cancer through directly targeting specificity protein 1. Tumour Biology, 39(6), 1010428317711323. https://doi.org/10.1177/1010428317711323
   Google Scholar
• Dowd, A. A., Homeida, S., & Elkarem, H. A. (2015). Detection of chromosome 13 (13q14) deletion among Sudanese patients with multiple myeloma using a molecular genetics fluorescent in situ hybridization technique (FISH). The Malaysian Journal of Pathology, 37(2), 95–100.
   PubMed Web of Science ®Google Scholar
• Du, L., Subauste, M. C., DeSevo, C., Zhao, Z., Baker, M., Borkowski, R., Schageman, J. J., Greer, R., Yang, C.-R., Suraokar, M., Wistuba, I. I., Gazdar, A. F., Minna, J. D., & Pertsemlidis, A. (2012). miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers. PLoS One, 7(6), e39167. https://doi.org/10.1371/journal.pone.0039167
   PubMed Web of Science ®Google Scholar
• Du, T., & Zamore, P. D. (2007). Beginning to understand microRNA function. Cell Research, 17(8), 661–663. https://doi.org/10.1038/cr.2007.67
   PubMed Web of Science ®Google Scholar
• Du, P., Zeng, H., Xiao, Y., Zhao, Y., Zheng, B., Deng, Y., Liu, J., Huang, B., Zhang, X., Yang, K., Jiang, Y., & Ma, X. (2020). Chronic stress promotes EMT-mediated metastasis through activation of STAT3 signaling pathway by miR-337-3p in breast cancer. Cell Death & Disease, 11(9), 761. https://doi.org/10.1038/s41419-020-02981-1
   PubMed Web of Science ®Google Scholar
• Fakeri, M., Koulaeizadeh, S., Armandzadeh, S. M., Aboutalebi Vand Beilankouhi, E., Valilo, M., & Alivand, M. R. (2024). Involvement of miRNA-337 in various cancers. Current Cancer Therapy Reviews, 20(2), 188–199. https://doi.org/10.2174/1573394719666230518112114
   Web of Science ®Google Scholar
• Fu, D., Shi, Y., Liu, J.-B., Wu, T.-M., Jia, C.-Y., Yang, H.-Q., Zhang, D.-D., Yang, X.-L., Wang, H.-M., & Ma, Y.-S. (2020). Targeting long non-coding RNA to therapeutically regulate gene expression in cancer. Molecular Therapy. Nucleic Acids, 21, 712–724. https://doi.org/10.1016/j.omtn.2020.07.005
   PubMedGoogle Scholar
• Gao, J., Chen, Q., Zhao, Y., & Hou, R. (2020). lncRNA CRNDE is upregulated in glioblastoma multiforme and facilitates cancer progression through targeting miR-337-3p and ELMOD2 axis. OncoTargets and Therapy, 13, 9225–9234. https://doi.org/10.2147/OTT.S249887
   PubMed Web of Science ®Google Scholar
• Gao, Q., Liu, Q., & Chen, H. (2021). Circular RNA hsa_circ_0000117 accelerates the proliferation and invasion of gastric cancer cells by regulating the microRNA-337-3p/signal transducer and activator of transcription 3 axis. Bioengineered, 12(1), 1381–1390. https://doi.org/10.1080/21655979.2021.1918992
   PubMed Web of Science ®Google Scholar
• Giza, D. E., Vasilescu, C., & Calin, G. A. (2014). Key principles of miRNA involvement in human diseases. Discoveries, 2(4), e34. https://doi.org/10.15190/d.2014.26
   Google Scholar
• Gong, T. T., Wu, Q. J., Vogtmann, E., Lin, B., & Wang, Y. L. (2013). Age at menarche and risk of ovarian cancer: A meta‐analysis of epidemiological studies. International Journal of Cancer, 132(12), 2894–2900. https://doi.org/10.1002/ijc.27952
   PubMed Web of Science ®Google Scholar
• He, M., Wang, Y., Cai, J., Xie, Y., Tao, C., Jiang, Y., Li, H., & Song, F. (2021). LncRNA DLEU2 promotes cervical cancer cell proliferation by regulating cell cycle and NOTCH pathway. Experimental Cell Research, 402(1), 112551. https://doi.org/10.1016/j.yexcr.2021.112551
   PubMed Web of Science ®Google Scholar
• Huan, J., Xing, L., Lin, Q., Xui, H., & Qin, X. (2017). Long noncoding RNA CRNDE activates Wnt/β-catenin signaling pathway through acting as a molecular sponge of microRNA-136 in human breast cancer. American Journal of Translational Research, 9(4), 1977–1989.
   PubMed Web of Science ®Google Scholar
• Huang, Y., Liu, N., Wang, J. P., Wang, Y. Q., Yu, X. L., Wang, Z. B., Cheng, X. C., & Zou, Q. (2012). Regulatory long non-coding RNA and its functions. Journal of Physiology and Biochemistry, 68(4), 611–618. https://doi.org/10.1007/s13105-012-0166-y
   PubMed Web of Science ®Google Scholar
• Huang, Y. F., Lu, L., Shen, H. L., & Lu, X. X. (2020). LncRNA SNHG4 promotes osteosarcoma proliferation and migration by sponging miR‐377‐3p. Molecular Genetics & Genomic Medicine, 8(8), e1349. https://doi.org/10.1002/mgg3.1349
   PubMed Web of Science ®Google Scholar
• Huang, Z., Ma, W., Xiao, J., Dai, X., & Ling, W. (2021). CircRNA_0092516 regulates chondrocyte proliferation and apoptosis in osteoarthritis through the miR-337-3p/PTEN axis. Journal of Biochemistry, 169(4), 467–475. https://doi.org/10.1093/jb/mvaa119
   PubMed Web of Science ®Google Scholar
• Huvila, J., Pors, J., Thompson, E. F., & Gilks, C. B. (2021). Endometrial carcinoma: Molecular subtypes, precursors and the role of pathology in early diagnosis. The Journal of Pathology, 253(4), 355–365. https://doi.org/10.1002/path.5608
   PubMed Web of Science ®Google Scholar
• Imani-Saber, Z., & Ghafouri-Fard, S. (2014). Promyelocytic leukemia gene functions and roles in tumorigenesis. Asian Pacific Journal of Cancer Prevention, 15(19), 8021–8028.
   PubMedGoogle Scholar
• Kehl, T., Backes, C., Kern, F., Fehlmann, T., Ludwig, N., Meese, E., Lenhof, H.-P., & Keller, A. (2017). About miRNAs, miRNA seeds, target genes and target pathways. Oncotarget, 8(63), 107167–107175. https://doi.org/10.18632/oncotarget.22363
   PubMedGoogle Scholar
• Kelsey, J. L., & Bernstein, L. (1996). Epidemiology and prevention of breast cancer. Annual Review of Public Health, 17(1), 47–67. https://doi.org/10.1146/annurev.pu.17.050196.000403
   PubMedGoogle Scholar
• Kikushige, Y. (2020). Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies. Journal of Clinical and Experimental Hematopathology: JCEH, 60(4), 146–158. https://doi.org/10.3960/jslrt.20036
   PubMed Web of Science ®Google Scholar
• Kim, S. Y., Lee, Y. H., & Bae, Y. S. (2012). MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting α subunit of protein kinase CKII in human colorectal cancer cells. Biochemical and Biophysical Research Communications, 429(3–4), 173–179. https://doi.org/10.1016/j.bbrc.2012.10.117
   PubMed Web of Science ®Google Scholar
• Kong, S., Liu, J., Zhang, B., Lv, F., Yu, Y., & Qin, T. (2022). MicroRNA-337-3p impedes breast cancer progression by targeting cyclin-dependent kinase 1. Oncology Letters, 23(1), 15. https://doi.org/10.3892/ol.2021.13133
   PubMed Web of Science ®Google Scholar
• Lanfredini, S., Thapa, A., & O'Neill, E. (2019). RAS in pancreatic cancer. Biochemical Society Transactions, 47(4), 961–972. https://doi.org/10.1042/BST20170521
   PubMedGoogle Scholar
• Lazarus, G., Dirjayanto, V. J., Sambowo, N. B., & Vianca, E. (2022). Detection of gestational diabetes mellitus by circulating plasma and serum microRNAs: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome, 16(1), 102383. https://doi.org/10.1016/j.dsx.2021.102383
   PubMed Web of Science ®Google Scholar
• Li, J., Wu, Q.-M., Wang, X.-Q., & Zhang, C.-Q. (2017). Long noncoding RNA miR210HG sponges miR-503 to facilitate osteosarcoma cell invasion and metastasis. DNA and Cell Biology, 36(12), 1117–1125. https://doi.org/10.1089/dna.2017.3888
   PubMed Web of Science ®Google Scholar
• Li, J., Xuan, Z., & Liu, C. (2013). Long non-coding RNAs and complex human diseases. International Journal of Molecular Sciences, 14(9), 18790–18808. https://doi.org/10.3390/ijms140918790
   PubMed Web of Science ®Google Scholar
• Li, Q., Huang, Q., Cheng, S., Wu, S., Sang, H., & Hou, J. (2019). Circ_ZNF124 promotes non-small cell lung cancer progression by abolishing miR-337-3p mediated downregulation of JAK2/STAT3 signaling pathway. Cancer Cell International, 19(1), 291. https://doi.org/10.1186/s12935-019-1011-y
   PubMed Web of Science ®Google Scholar
• Li, Z., Tang, Y., Xing, W., Dong, W., & Wang, Z. (2018). LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition. Experimental and Molecular Pathology, 104(1), 19–25. https://doi.org/10.1016/j.yexmp.2017.12.002
   PubMed Web of Science ®Google Scholar
• Liu, W., Liu, P. C., Ma, K., Wang, Y. y., Chi, Q. B., & Yan, M. (2020). LncRNA DLEU2 promotes tumour growth by sponging miR‐337‐3p in human osteosarcoma. Cell Biochemistry and Function, 38(7), 886–894. https://doi.org/10.1002/cbf.3509
   PubMed Web of Science ®Google Scholar
• Liu, T., Zhang, X., Gao, S., Jing, F., Yang, Y., Du, L., Zheng, G., Li, P., Li, C., & Wang, C. (2016). Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer. Oncotarget, 7(51), 85551–85563. https://doi.org/10.18632/oncotarget.13465
   PubMed Web of Science ®Google Scholar
• Lossi, L., Castagna, C., & Merighi, A. (2018). Caspase-3 mediated cell death in the normal development of the mammalian cerebellum. International Journal of Molecular Sciences, 19(12), 3999. https://doi.org/10.3390/ijms19123999
   PubMed Web of Science ®Google Scholar
• Ma, J., Kong, F.-F., Yang, D., Yang, H., Wang, C., Cong, R., & Ma, X.-X. (2021). lncRNA MIR210HG promotes the progression of endometrial cancer by sponging miR-337-3p/137 via the HMGA2-TGF-β/Wnt pathway. Molecular Therapy. Nucleic Acids, 24, 905–922. https://doi.org/10.1016/j.omtn.2021.04.011
   PubMedGoogle Scholar
• Maxwell, G. L., Chandramouli, G., Litzi, T., Berchuck, A., Conrads, T. P., & Risinger, J. I. (2013). Analysis of micro RNAs in the racial disparity of endometrial cancer. AACR.
   Google Scholar
• Meng, Q-h., Li, Y., Kong, C., Gao, X-M., & Jiang, X-J (2021). Circ_0000388 exerts oncogenic function in cervical cancer cells by regulating miR-337-3p/TCF12 axis. Cancer Biotherapy & Radiopharmaceuticals, 36(1), 58–69. https://doi.org/10.1089/cbr.2019.3159
   PubMed Web of Science ®Google Scholar
• Pan, Y., Zhao, Y., Lihui, L., Xie, Y., & Zou, Q. (2021). MiR-337-3p suppresses migration and invasion of breast cancer cells by downregulating ESRP1. Acta Histochemica, 123(7), 151777. https://doi.org/10.1016/j.acthis.2021.151777
   PubMed Web of Science ®Google Scholar
• Park, J. K., Doseff, A. I., & Schmittgen, T. D. (2018). MicroRNAs targeting caspase-3 and -7 in PANC-1 cells. International Journal of Molecular Sciences, 19(4), 1206. https://doi.org/10.3390/ijms19041206
   PubMed Web of Science ®Google Scholar
• Petrick, J. L., Campbell, P. T., Koshiol, J., Thistle, J. E., Andreotti, G., Beane-Freeman, L. E., Buring, J. E., Chan, A. T., Chong, D. Q., Doody, M. M., Gapstur, S. M., Gaziano, J. M., Giovannucci, E., Graubard, B. I., Lee, I.-M., Liao, L. M., Linet, M. S., Palmer, J. R., Poynter, J. N., … McGlynn, K. A. (2018). Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. British Journal of Cancer, 118(7), 1005–1012. https://doi.org/10.1038/s41416-018-0007-z
   PubMed Web of Science ®Google Scholar
• Qi, X., Zhang, D.-H., Wu, N., Xiao, J.-H., Wang, X., & Ma, W. (2015). ceRNA in cancer: Possible functions and clinical implications. Journal of Medical Genetics, 52(10), 710–718. https://doi.org/10.1136/jmedgenet-2015-103334
   PubMed Web of Science ®Google Scholar
• Qin, Y., Sun, W., Wang, Z., Dong, W., He, L., Zhang, T., & Zhang, H. (2020). Long non-coding Small Nucleolar RNA Host Genes (SNHGs) in endocrine-related cancers. OncoTargets and Therapy, 13, 7699–7717. https://doi.org/10.2147/OTT.S267140
   PubMed Web of Science ®Google Scholar
• Rani, V., & Sengar, R. (2022). Biogenesis and mechanisms of miRNA‐mediated gene regulation. Biotechnology and Bioengineering, 119(3), 685–692. https://doi.org/10.1002/bit.28029
   PubMed Web of Science ®Google Scholar
• Reddy, K. B. (2015). MicroRNA (miRNA) in cancer. Cancer Cell International, 15(1), 38. https://doi.org/10.1186/s12935-015-0185-1
   PubMed Web of Science ®Google Scholar
• Samir, A., Salama, E., & El-Tayebi, H. (2018). The long non-coding RNA XIST: A new cornerstone in carcinogenesis. Journal of Molecular and Genetic Medicine, 12(2), 0862.1000356. https://doi.org/10.4172/1747-0862.1000356
   Google Scholar
• Shang, Q., Yang, Z., Jia, R., & Ge, S. (2019). The novel roles of circRNAs in human cancer. Molecular Cancer, 18(1), 6. https://doi.org/10.1186/s12943-018-0934-6
   PubMed Web of Science ®Google Scholar
• Shenouda, S. K., & Alahari, S. K. (2009). MicroRNA function in cancer: Oncogene or a tumor suppressor? Cancer Metastasis Reviews, 28(3–4), 369–378. https://doi.org/10.1007/s10555-009-9188-5
   PubMed Web of Science ®Google Scholar
• Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70(1), 7–30. https://doi.org/10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Stein, L. D. (2004). End of the beginning. Nature, 431(7011), 915–916. https://doi.org/10.1038/431915a
   PubMed Web of Science ®Google Scholar
• Su, L., Li, R., Zhang, Z., Liu, J., Du, J., & Wei, H. (2022). Identification of altered exosomal microRNAs and mRNAs in Alzheimer’s disease. Ageing Research Reviews, 73, 101497. https://doi.org/10.1016/j.arr.2021.101497
   PubMed Web of Science ®Google Scholar
• Tang, D., Zhao, L., Peng, C., Ran, K., Mu, R., & Ao, Y. (2019). LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR‐337‐3p. Journal of Cellular Biochemistry, 120(9), 16128–16142. https://doi.org/10.1002/jcb.28894
   PubMed Web of Science ®Google Scholar
• Tang, Q., Zheng, X., & Zhang, J. (2018). Long non-coding RNA CRNDE promotes heptaocellular carcinoma cell proliferation by regulating PI3K/Akt/β-catenin signaling. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 103, 1187–1193. https://doi.org/10.1016/j.biopha.2018.04.128
   PubMed Web of Science ®Google Scholar
• Tao, W., Jia, Z., Mengshi, W., Wei, L., & Feng, L. (2020). Circular RNA circFANCL motivates the glioma progression via the action on the miR-337-3p/HMGB1 signal axis. Minerva Medica. https://doi.org/10.23736/S0026-4806.20.06639-2
   Google Scholar
• Verduci, L., Tarcitano, E., Strano, S., Yarden, Y., & Blandino, G. (2021). CircRNAs: Role in human diseases and potential use as biomarkers. Cell Death & Disease, 12(5), 468. https://doi.org/10.1038/s41419-021-03743-3
   PubMed Web of Science ®Google Scholar
• Vogt, P. H., Bender, U., Zimmer, J., & Strowitzki, T. (2017). Human Y chromosome and male infertility: Forward and back from azoospermia factor chromatin structure to azoospermia factor gene function. In P. H. Vogt & S. Karger AG (Eds.), Genetics of human infertility (Vol. 21, pp. 57–73). Karger Publishers.
   Google Scholar
• Vonhögen, I. G. C., El Azzouzi, H., Olieslagers, S., Vasilevich, A., de Boer, J., Tinahones, F. J., da Costa Martins, P. A., de Windt, L. J., & Murri, M. (2020). MiR-337-3p promotes adipocyte browning by inhibiting TWIST1. Cells, 9(4), 1056. https://doi.org/10.3390/cells9041056
   PubMed Web of Science ®Google Scholar
• Wagner, A. D., Unverzagt, S., Grothe, W., Kleber, G., Grothey, A., Haerting, J., & Fleig, W. E. (2017). Chemotherapy for advanced gastric cancer. The Cochrane Database of Systematic Reviews, (8), Cd004064. https://doi.org/10.1002/14651858.CD004064.pub4
   PubMed Web of Science ®Google Scholar
• Wang, H., Ke, J., Guo, Q., Barnabo Nampoukime, K. P., Yang, P., & Ma, K. (2018). Long non‐coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR‐217/MAPK 1 axis. Journal of Cellular and Molecular Medicine, 22(12), 5862–5876. https://doi.org/10.1111/jcmm.13856
   PubMed Web of Science ®Google Scholar
• Wang, Y., Li, W., Chen, X., Li, Y., Wen, P., & Xu, F. (2019). MIR210HG predicts poor prognosis and functions as an oncogenic lncRNA in hepatocellular carcinoma. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 111, 1297–1301. https://doi.org/10.1016/j.biopha.2018.12.134
   PubMed Web of Science ®Google Scholar
• Wang, Y., Wang, L., Wang, W., & Guo, X. (2020). Overexpression of circular RNA hsa_circ_0001038 promotes cervical cancer cell progression by acting as a ceRNA for miR-337-3p to regulate cyclin-M3 and metastasis-associated in colon cancer 1 expression. Gene, 733, 144273. https://doi.org/10.1016/j.gene.2019.144273
   PubMed Web of Science ®Google Scholar
• Wang, Z., Wang, J., Yang, Y., Hao, B., Wang, R., Li, Y., & Wu, Q. (2013). Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer. Journal of Experimental & Clinical Cancer Research, 32(1), 1–9. https://doi.org/10.1186/1756-9966-32-76
   PubMedGoogle Scholar
• Wang, W., & Yang, J. (2020). Long noncoding RNA TTTY15 promotes growth and metastasis of esophageal squamous cell carcinoma by sponging microRNA-337-3p to upregulate the expression of JAK2. Anti-Cancer Drugs, 31(10), 1038–1045. https://doi.org/10.1097/CAD.0000000000000960
   PubMed Web of Science ®Google Scholar
• Wang, Z., Yao, L., Li, Y., Hao, B., Wang, M., Wang, J., Gu, W., Zhan, H., Liu, G., & Wu, Q. (2020). miR‑337‑3p inhibits gastric tumor metastasis by targeting ARHGAP10. Molecular Medicine Reports, 21(2), 705–719. https://doi.org/10.3892/mmr.2019.10856
   PubMed Web of Science ®Google Scholar
• Wang, X., Zhang, G., Cheng, Z., Dai, L., Jia, L., Jing, X., Wang, H., Zhang, R., Liu, M., Jiang, T., Yang, Y., & Yang, M. (2018). Knockdown of LncRNA-XIST suppresses proliferation and TGF-β1-induced EMT in NSCLC through the Notch-1 pathway by regulation of miR-137. Genetic Testing and Molecular Biomarkers, 22(6), 333–342. https://doi.org/10.1089/gtmb.2018.0026
   PubMed Web of Science ®Google Scholar
• Wattanathamsan, O., Hayakawa, Y., & Pongrakhananon, V. (2019). Molecular mechanisms of natural compounds in cell death induction and sensitization to chemotherapeutic drugs in lung cancer. Phytotherapy Research: PTR, 33(10), 2531–2547. https://doi.org/10.1002/ptr.6422
   PubMed Web of Science ®Google Scholar
• Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y., Huang, K. H., Lee, M. J., Galas, D. J., & Wang, K. (2010). The microRNA spectrum in 12 body fluids. Clinical Chemistry, 56(11), 1733–1741. https://doi.org/10.1373/clinchem.2010.147405
   PubMed Web of Science ®Google Scholar
• Wong, C., Wellman, T. L., & Lounsbury, K. M. (2003). VEGF and HIF-1α expression are increased in advanced stages of epithelial ovarian cancer. Gynecologic Oncology, 91(3), 513–517. https://doi.org/10.1016/j.ygyno.2003.08.022
   PubMed Web of Science ®Google Scholar
• Wu, W., Wu, Z., Xia, Y., Qin, S., Li, Y., Wu, J., Liang, J., Wang, L., Zhu, H., Fan, L., Fu, J., Xu, W., Jin, H., & Li, J. (2019). Downregulation of circ_0132266 in chronic lymphocytic leukemia promoted cell viability through miR-337-3p/PML axis. Aging, 11(11), 3561–3573. https://doi.org/10.18632/aging.101997
   PubMedGoogle Scholar
• Xia, L., Wu, L., Xia, H., Bao, J., Li, Q., Chen, X., & Xia, R. (2019). miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway. Cell Cycle, 18(14), 1635–1645. https://doi.org/10.1080/15384101.2019.1629789
   PubMed Web of Science ®Google Scholar
• Xiang, X., Mei, H., Zhao, X., Pu, J., Li, D., Qu, H., Jiao, W., Zhao, J., Huang, K., Zheng, L., & Tong, Q. (2015). miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14. Oncotarget, 6(26), 22452–22466. https://doi.org/10.18632/oncotarget.4311
   PubMedGoogle Scholar
• Xiao, G., Yao, J., Kong, D., Ye, C., Chen, R., Li, L., Zeng, T., Wang, L., Zhang, W., Shi, X., Zhou, T., Li, J., Wang, Y., Xu, C. L., Jiang, J., & Sun, Y. (2019). The long noncoding RNA TTTY15, which is located on the Y chromosome, promotes prostate cancer progression by sponging let-7. European Urology, 76(3), 315–326. https://doi.org/10.1016/j.eururo.2018.11.012
   PubMed Web of Science ®Google Scholar
• Xu, L., Gao, J., Zheng, J., Zhao, Z., Zhong, X., Sun, J., & Li, D. (2019). lncRNA XIST promotes gastric cancer progression via regulating miR-337-3p/HOXC8 axis. Chinese Journal of Cancer Biotherapy, 6, 1134–1141.
   Google Scholar
• Xv, Y., Qiu, M., Liu, Z., Xiao, M., & Wang, F. (2022). Development of a 7-miRNA prognostic signature for patients with bladder cancer. Aging,), 14(24), 10093–10106. https://doi.org/10.18632/aging.204447
   PubMedGoogle Scholar
• Yang, H., Guo, J., Zhang, M., & Li, A. (2020). LncRNA SNHG4 promotes neuroblastoma proliferation, migration, and invasion by sponging miR-377-3p. Neoplasma, 67(5), 1054–1062. https://doi.org/10.4149/neo_2020_191023N1081
   PubMed Web of Science ®Google Scholar
• Ye, J., Xu, M., Tian, X., Cai, S., & Zeng, S. (2019). Research advances in the detection of miRNA. Journal of Pharmaceutical Analysis, 9(4), 217–226. https://doi.org/10.1016/j.jpha.2019.05.004
   PubMed Web of Science ®Google Scholar
• Yoon, J.-H., Abdelmohsen, K., & Gorospe, M. (2014). Functional interactions among microRNAs and long noncoding RNAs. Seminars in Cell & Developmental Biology, 34, 9–14. https://doi.org/10.1016/j.semcdb.2014.05.015
   PubMed Web of Science ®Google Scholar
• Zhang, F., Wang, H., Yu, J., Yao, X., Yang, S., Li, W., Xu, L., & Zhao, L. (2021). LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM. Molecular Cancer, 20(1), 6. https://doi.org/10.1186/s12943-020-01299-y
   PubMed Web of Science ®Google Scholar
• Zhang, Z., Zhang, L., Wang, B., Wei, R., Wang, Y., Wan, J., Zhang, C., Zhao, L., Zhu, X., Zhang, Y., Chu, C., Guo, Q., Yin, X., & Li, X. (2020). MiR-337–3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB. Cancer Letters, 469, 54–67. https://doi.org/10.1016/j.canlet.2019.10.021
   PubMed Web of Science ®Google Scholar
• Zheng, X.-Y., Cao, M.-Z., Ba, Y., Li, Y.-F., & Ye, J.-L. (2021). LncRNA testis-specific transcript, Y-linked 15 (TTTY15) promotes proliferation, migration and invasion of colorectal cancer cells via regulating miR-29a-3p/DVL3 axis. Cancer Biomarkers, 31(1), 1–11. https://doi.org/10.3233/CBM-201709
   PubMed Web of Science ®Google Scholar
• Zheng, L., Jiao, W., Mei, H., Song, H., Li, D., Xiang, X., Chen, Y., Yang, F., Li, H., Huang, K., & Tong, Q. (2016). miRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14. Oncotarget, 7(26), 40314–40328. https://doi.org/10.18632/oncotarget.9739
   PubMedGoogle Scholar
• Zheng, W., Li, J., Zhou, X., Cui, L., & Wang, Y. (2020). The lncRNA XIST promotes proliferation, migration and invasion of gastric cancer cells by targeting miR-337. Arab Journal of Gastroenterology, 21(3), 199–206. https://doi.org/10.1016/j.ajg.2020.07.010
   PubMed Web of Science ®Google Scholar
• Zhong, Y., Lin, H., Li, Q., Liu, C., & Shen, J. (2021). CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis. Cancer Biomarkers: Section A of Disease Markers, 30(2), 261–273. https://doi.org/10.3233/CBM-201705
   PubMed Web of Science ®Google Scholar
• Zhou, X.-Y., Yang, H., Bai, Y.-Q., Li, X.-L., Han, S.-Y., & Zhou, B.-X. (2020). hsa_circ_0006916 promotes hepatocellular carcinoma progression by activating the miR-337-3p/STAT3 axis. Cellular & Molecular Biology Letters, 25(1), 47. https://doi.org/10.1186/s11658-020-00238-5
   PubMed Web of Science ®Google Scholar
• Zhuang, Q., Shen, J., Chen, Z., Zhang, M., Fan, M., Xue, D., Lu, H., Xu, R., He, X., & Hou, J. (2018). MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4. Cancer Biomarkers: Section A of Disease Markers, 23(4), 515–525. https://doi.org/10.3233/CBM-181645
   PubMed Web of Science ®Google Scholar
• Zuo, X.-L., Chen, Z.-Q., Wang, J.-F., Wang, J.-G., Liang, L.-H., & Cai, J. (2018). miR-337-3p suppresses the proliferation and invasion of hepatocellular carcinoma cells through targeting JAK2. American Journal of Cancer Research, 8(4), 662–674.
   PubMed Web of Science ®Google Scholar
• Zuo, K., Zhao, Y., Zheng, Y., Chen, D., Liu, X., Du, S., & Liu, Q. (2019). Long non-coding RNA XIST promotes malignant behavior of epithelial ovarian cancer. OncoTargets and Therapy, 12, 7261–7267. https://doi.org/10.2147/OTT.S204369
   PubMed Web of Science ®Google Scholar